Curcumin Has Potent Anti-Amyloidogenic Effects for Alzheimer's β-Amyloid Fibrils In Vitro

Journal of Neuroscience Research

Volumn 75, Issue 6, 2004, Pages 742-750

  Ono, Kenjiro ^a   Hasegawa, Kazuhiro ^b,c   Naiki, Hironobu ^b,c   Yamada, Masahito ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

amyloid fibrils; Alzheimer's disease; Curcumin; Electron microscopy; Thioflavin T

Indexed keywords

AMYLOID BETA PROTEIN; CURCUMIN; NORDIHYDROGUAIARETIC ACID; POLYPHENOL; ROSMARINIC ACID; THIOFLAVINE;

ALZHEIMER DISEASE; ANTIAMYLOIDOGENIC EFFECT; ARTICLE; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; DRUG STRUCTURE; ELECTRON MICROSCOPY; FLUORESCENCE SPECTROSCOPY; IN VITRO STUDY; POLARIZATION MICROSCOPY; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CINNAMATES; CURCUMIN; DEPSIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; KINETICS; LIPOXYGENASE INHIBITORS; MICROSCOPY, ELECTRON; MICROSCOPY, POLARIZATION; NEUROFIBRILLARY TANGLES; NORDIHYDROGUAIARETIC ACID; PEPTIDE FRAGMENTS; PLATELET AGGREGATION INHIBITORS; SPECTROMETRY, FLUORESCENCE; THIAZOLES; TIME FACTORS;

EID: 1542364225     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20025     Document Type: Article

References (57)

1. Behl C, Davis J, Cole GM, Schubert D. 1992. Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem Biophys Res Commun 186:944-950.
2. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
3. Cacabelos R, Alvarez A, Lombardi A, Fernandez-Novoa L, Corzo L, Perez P, Laredo M, Pichel V, Hernandez A, Varela M, Figueroa J, Prous J, Windisch M, Vigo C. 2000. Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics. Drugs Today 36:415-499.
4. Caughey B, Raymond LD, Raymond GJ, Maxson L, Silveira J, Baron GS. 2003. Inhibition of protease-resistant prion protein accumulation in vitro by curcumin. J Virol 77:5499-5502.
5. Chan MM, Huang HI, Fenton MR, Fong D. 1998. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem Pharmacol 55:1955-1962.
6. Forloni G, Colombo L, Girola L, Tagliavini F, Salmona M. 2001. Antiamyloidogenic activity of tetracyclines: studies in vitro. FEBS Lett 487:404-407.
7. Ganguli M, Chandra V, Kamboh MI, Johnston JM, Dodge HH, Thelma BK, Juyal RC, Pandav R, Belle SH, DeKosky ST. 2000. Apolipoprotein E polymorphism and Alzheimer disease: the Indo-US Cross-National Dementia Study. Arch Neurol 57:824-830.
8. Goodman Y, Steiner MR, Steiner SM, Mattson MP. 1994. Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res 654:171-176.
9. Grundman M, Delaney P. 2002. Antioxidant strategies for Alzheimer's disease. Proc Nutr Soc 61:191-202.
10. Hasegawa K, Ono K, Yamada M, Naiki H. 2002. Kinetic modeling and determination of reaction constants of Alzheimer's β-amyloid fibril extension and dissociation using surface plasmon resonance. Biochemistry 41:13489-13498.
11. Hasegawa K, Yamaguchi I, Omata S, Gejyo F, Naiki H. 1999. Interaction between A beta(1-42) and A beta(1-40) in Alzheimer's beta-amyloid fibril formation in vitro. Biochemistry 38:15514-15521.
12. Jama JW, Launer LJ, Witteman JC, den Breeijen JH, Breteler MM, Grobbee DE, Hofman A. 1996. Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. Am J Epidemiol 144:275-280.
13. Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Horne P, Heslin D, French J, Mount HT, Nixon RA, Mercken M, Bergeron C, Fraser PE, St George-Hyslop P, Westaway D. 2000. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408:979-982.
14. Jarrett JT, Lansbury PT Jr. 1993. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73:1055-1058.
15. Kaul S, Krishnakantha TP. 1997. Influence of retinol deficiency and curcumin/turmeric feeding on tissue microsomal membrane lipid peroxidation and fatty acids in rats. Mol Cell Biochem 175:43-48.
16. Kelloff GJ, Crowell JA, Hawk ET, Steele VE, Lubet RA, Boone CW, Covey JM, Doody LA, Omenn GS, Greenwald P, Hong WK, Parkinson DR, Bagheri D, Baxter GT, Blunden M, Doeltz MK, Eisenhauer KM, Johnson K, Knapp GG, Longfellow DG, Malone WF, Nayfield SG, Seifried HE, Swall LM, Sigman CC. 1996. Strategy and planning for chemopreventive drug development: clinical development plans II. J Cell Biochem Suppl 26:54-71.
17. Kelloff GJ, Crowell JA, Steele VE, Lubet RA, Malone WA, Boone CW, Kopelovich L, Hawk ET, Lieberman R, Lawrence JA, Ali I, Viner JL, Sigman CC. 2000. Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J Nutr 130(Suppl):467-471.
18. Kihara T, Shimohama S, Sawada H, Kimura J, Kume T, Kochiyama H, Maeda T, Akaike A. 1997. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity. Ann Neurol 42:159-163.
19. Kim DS, Park SY, Kim JK. 2001. Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA(1-42) insult. Neurosci Lett 303:57-61.
20. Kisilevsky R, Lemieux LJ, Fraser PE, Kong X, Hultin PG, Szarek WA. 1995. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease. Nat Med 1:143-148.
21. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. 2001. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21:8370-8377.
22. Lomakin A, Teplow DB, Kirschner DA, Benedek GB. 1997. Kinetic theory of fibrillogenesis of amyloid beta-protein. Proc Natl Acad Sci USA 94:7942-7947.
23. Luo J, Chuang T, Cheung J, Quan J, Tsai J, Sullivan C, Hector RF, Reed MJ, Meszaros K, King SR, Carlson TJ, Reaven GM. 1998. Masoprocol (nordihydroguaiaretic acid): a new antihyperglycemic agent isolated from the creosote bush (Larrea tridentata). Eur J Pharmacol 346:77-79.
24. Martin-Aragon S, Benedi JM, Villar AM. 1997. Modifications on antioxidant capacity and lipid peroxidation in mice under fraxetin treatment. J Pharm Pharmacol 49:49-52.
25. Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW. 2000. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408:982-985.
26. Naiki H, Gejyo F. 1999. Kinetic analysis of amyloid fibril formation. Methods Enzymol 309:305-318.
27. Naiki H, Gejyo F, Nakakuki K. 1997. Concentration-dependent inhibitory effects of apolipoprotein E on Alzheimer's beta-amyloid fibril formation in vitro. Biochemistry 36:6243-6250.
28. Naiki H, Hasegawa K, Yamaguchi I, Nakamura H, Gejyo F, Nakakuki K. 1998. Apolipoprotein E and antioxidants have different mechanisms of inhibiting Alzheimer's beta-amyloid fibril formation in vitro. Biochemistry 37:17882-17889.
29. Naiki H, Nakakuki K. 1996. First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro. Lab Invest 74:374-383.
30. Ono K, Hasegawa K, Yamada M, Naiki H. 2002a. Nicotine breaks down preformed Alzheimer's beta-amyloid fibrils in vitro. Biol Psychiatry 52:880-886.
31. Ono K, Hasegawa K, Yoshiike Y, Takashima A, Yamada M, Naiki H. 2002b. Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's beta-amyloid fibrils in vitro. J Neurochem 81:434-440.
32. Ono K, Yoshiike Y, Takashima A, Hasegawa K, Naiki H, Yamada M. 2003. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: Implications for the prevention and therapeutics of Alzheimer's disease. J Neurochem 87:172-181.
33. Pappolla M, Bozner P, Soto C, Shao H, Robakis NK, Zagorski M, Frangione B, Ghiso J. 1998. Inhibition of Alzheimer beta-fibrillogenesis by melatonin. J Biol Chem 273:7185-7188.
34. Parnham MJ, Kesselring K. 1985. Rosmarinic acid. Drugs Future 10:756-757.
35. Pereira C, Santos MS, Oliveira C. 1999. Involvement of oxidative stress on the impairment of energy metabolism induced by A beta peptides on PC12 cells: protection by antioxidants. Neurobiol Dis 6:209-219.
36. Perrig WJ, Perrig P, Stahelin HB. 1997. The relation between antioxidants and memory performance in the old and very old. J Am Geriatr Soc 45:718-724.
37. Petersen M, Simmonds MS. 2003. Rosmarinic acid. Phytochemistry 62:121-125.
38. Pratico D, Delanty N. 2000. Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease. Am J Med 109:577-585.
39. Rajakrishnan V, Viswanathan P, Rajasekharan KN, Menon VP. 1999. Neuroprotective role of curcumin from curcuma longa on ethanol-induced brain damage. Phytother Res 13:571-574.
40. Roth A, Schaffner W, Hertel C. 1999. Phytoestrogen kaempferol (3,4′,5,7-tetrahydroxyflavone) protects PC12 and T47D cells from beta-amyloid-induced toxicity. J Neurosci Res 57:399-404.
41. Rottkamp CA, Nunomura A, Raina AK, Sayre LM, Perry G, Smith MA. 2000. Oxidative stress, antioxidants, and Alzheimer disease. Alzheimer Dis Assoc Disord 14(Suppl):62-66.
42. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P. 1999. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173-177.
43. Selkoe DJ. 2001. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81:741-766.
44. Skovronsky DM, Lee VM. 2000. Beta-secretase revealed: starting gate for race to novel therapies for Alzheimer's disease. Trends Pharmacol Sci 21:161-163.
45. Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G. 2000. Oxidative stress in Alzheimer's disease. Biochim Biophys Acta 1502:139-144.
46. Soto C, Kindy MS, Baumann M, Frangione B. 1996. Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. Biochem Biophys Res Commun 226:672-680.
47. Sreejayan, Rao MN. 1997. Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol 49:105-107.
48. Subramaniam R, Koppal T, Green M, Yatin S, Jordan B, Drake J, Butterfield DA. 1998. The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide(25-35) toxicity but not from hydroxynonenal toxicity: relevance to the free radical hypothesis of Alzheimer's disease. Neurochem Res 23:1403-1410.
49. Tomiyama T, Asano S, Suwa Y, Morita T, Kataoka K, Mori H, Endo N. 1994. Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in vitro. Biochem Biophys Res Commun 204:76-83.
50. Tomiyama T, Shoji A, Kataoka K, Suwa Y, Asano S, Kaneko H, Endo N. 1996. Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. J Biol Chem 271:6839-6844.
51. Varadarajan S, Yatin S, Aksenova M, Butterfield DA. 2000. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol 130:184-208.
52. Xu YX, Pindolia KR, Janakiraman N, Chapman RA, Gautam SC. 1998. Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells. Hematopathol Mol Hematol 11:49-62.
53. Yatin SM, Yatin M, Aulick T, Ain KB, Butterfield DA. 1999. Alzheimer's amyloid beta-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: protective effect of vitamin E. Neurosci Lett 263:17-20.
54. Zeng H, Zhang Y, Peng LJ, Shao H, Menon NK, Yang J, Salomon AR, Freidland RP, Zagorski MG. 2001. Nicotine and amyloid formation. Biol Psychiatry 49:248-257.
55. Zhang F, Altorki NK, Mestre, JR, Subbaramaiah K, Dannenberg AJ. 1999. Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis 20:445-451.
56. Zhao BL, Li XJ, He RG, Cheng SJ, Xin WJ. 1989. Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Cell Biophys 14:175-185.
57. Zhou Y, Gopalakrishnan V, Richardson JS. 1996. Actions of neurotoxic beta-amyloid on calcium homeostasis and viability of PC12 cells are blocked by antioxidants but not by calcium channel antagonists. J Neurochem 67:1419-1425.